Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Shares Outstanding (2019 - 2026)

Updated

Aligos Therapeutics (ALGS) recorded Weighted Average Shares Outstanding of 10.46 million in Q3 2026, up 0.9% from 10.37 million a year earlier and up 0.3% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Shares Outstanding (2019 - 2026) Analysis & Trends

For FY2025, Aligos Therapeutics reported Weighted Average Shares Outstanding of 9.88 million, up 57.8% from FY2024.

  • Annual Weighted Average Shares Outstanding has a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
  • Across earlier years, Weighted Average Shares Outstanding came in at 6.26 million in FY2024 (-90.3%), 64.26 million in FY2023 (+50.5%), 42.7 million in FY2022 (+7.1%) and 39.86 million in FY2021 (+299.0%).
  • The Q3 2026 figure is the highest quarterly Weighted Average Shares Outstanding since Q2 2024.
  • On a year-over-year basis, Weighted Average Shares Outstanding has increased for five consecutive quarters, with an average decline of 16.2% over the last eight quarters.
  • Peak year-over-year performance for Weighted Average Shares Outstanding in the last five years was growth of 299.0% in Q4 2021, against a decline of 94.6% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at 10.43 million (Q2 2026), 10.4 million (Q1 2026) and 9.88 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.41 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 1.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 1.94 Bn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.55 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.24 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 5.70 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - 10.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.46 Mn
Jun 30, 2026 10.43 Mn
Mar 31, 2026 10.40 Mn
Dec 31, 2025 9.88 Mn
Sep 30, 2025 10.37 Mn
Jun 30, 2025 10.35 Mn
Mar 31, 2025 8.41 Mn
Dec 31, 2024 6.26 Mn
Sep 30, 2024 6.27 Mn
Jun 30, 2024 156.44 Mn
Mar 31, 2024 156.15 Mn
Dec 31, 2023 64.26 Mn
Sep 30, 2023 43.50 Mn
Jun 30, 2023 43.22 Mn
Mar 31, 2023 42.91 Mn
Dec 31, 2022 42.70 Mn
Sep 30, 2022 42.76 Mn
Jun 30, 2022 42.67 Mn
Mar 31, 2022 42.51 Mn
Dec 31, 2021 39.86 Mn
API Access

Aligos Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ALGS&period=max&api_key=YOUR_API_KEY